EUVIMEDEUVIMED entdecken
Open Access

Insurance Type and Menopausal Hormone Therapy Use Among US Women

Arina Chesnokova, Sunni L Mumford, Allison Schachter, Rebecca F Hamm, Scott Lorch, Matthew Klebanoff, Sarah Lindley, Erika Harness, Makeba Williams, Marilyn M Schapira

JAMA Network Open · 17.07.2026 · 9 (7) · e2623740

DOI: 10.1001/jamanetworkopen.2026.23740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 17.07.2026. Verfasst von Arina Chesnokova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia. Hauptthemen laut MEDLINE: Medicaid, Insurance Coverage, Menopause, Insurance, Health. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Access to menopausal hormone therapy (MHT) in the US remains low. Understanding whether insurance type is associated with MHT underuse and racial disparities in menopausal care is critical for designing interventions that increase evidence-based and equitable menopause care.

Objective

To examine whether Medicaid compared with private insurance is associated with lower MHT use among US women. A secondary objective explored the degree that payer type is associated with observed racial differences in MHT use. Design, Setting, and Participants This cross-sectional study used the 2013-2014, 2015-2016, and 2017-2020 cycles of the National Health and Nutrition Examination Survey (NHANES) to identify a survey-weighted analytic subset of eligible respondents of a population-based survey of the US civilian, noninstitutionalized population. The study included women aged 45 to 64 years with Medicaid or private insurance coverage who were eligible for MHT. Statistical analyses were performed between March 26, 2024, and December 2, 2025. Exposure Insurance type. Main Outcomes and Measures MHT use was the primary outcome. A secondary analysis assessed whether insurance status was associated with observed racial differences in MHT use. Associations were estimated using multivariable logistic regression.

Results

The unweighted sample included 1666 National Health and Nutrition Examination Survey respondents (n = 22 275 545, weighted). Of the weighted final sample, 91.4% had private insurance, and 8.6% had Medicaid. Individuals insured by Medicaid were less likely than those with private insurance to report a history of MHT use (10.7% [95% CI, 6.9%-16.0%] vs 20.7% [95% CI, 18.1%-23.5%]). After adjustment, Medicaid-insured women had lower odds of MHT use than privately insured women (OR, 0.50 [95% CI, 0.28-0.87]). In a secondary analysis, Black participants showed lower odds of MHT than White participants (OR, 0.68 [95% CI, 0.45-0.95]), but this difference was attenuated once insurance status was included in the model (adjusted OR, 0.72 [95% CI, 0.50-1.04]). Conclusions and Relevance In this cross-sectional study of women at typical age for menopause, Medicaid coverage was associated with significantly lower MHT use, suggesting that insurance type may play a role in menopausal care disparities. Insurance status may also partially explain previously observed racial gaps in MHT use. These findings highlight the need for policy and clinical interventions to address insurance-related barriers and to promote equitable menopausal care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicaidInsurance CoverageMenopauseInsurance, HealthHormone Replacement TherapyEstrogen Replacement TherapyHumansFemaleUnited StatesCross-Sectional StudiesMiddle AgedNutrition SurveysHealthcare DisparitiesHealth Services Accessibility

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
  • Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Division of Neonatology, Department of Pediatrics and Center for Pediatric and Perinatal Health Disparities Research and Policy Lab, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Sidney Kimmel Medical College, Thomas Jefferson Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Zitieren

APA

Chesnokova, A., Mumford, S. L., Schachter, A., Hamm, R. F., Lorch, S., Klebanoff, M., Lindley, S., Harness, E., Williams, M., & Schapira, M. M. (2026). Insurance Type and Menopausal Hormone Therapy Use Among US Women. JAMA Network Open, 9(7), e2623740. https://doi.org/10.1001/jamanetworkopen.2026.23740

Vancouver

Chesnokova A, Mumford SL, Schachter A, Hamm RF, Lorch S, Klebanoff M, et al. Insurance Type and Menopausal Hormone Therapy Use Among US Women. JAMA Network Open. 2026;9(7):e2623740. doi:10.1001/jamanetworkopen.2026.23740

BibTeX
@article{Chesnokova2026,
  author = {Chesnokova, Arina and Mumford, Sunni L and Schachter, Allison and Hamm, Rebecca F and Lorch, Scott and Klebanoff, Matthew and Lindley, Sarah and Harness, Erika and Williams, Makeba and Schapira, Marilyn M},
  title = {Insurance Type and Menopausal Hormone Therapy Use Among US Women},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {7},
  pages = {e2623740},
  doi = {10.1001/jamanetworkopen.2026.23740}
}
Kostenlos starten →